

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.21537309 |
| 2 | central nervous system myelination (GO:0022010) | 7.21537309 |
| 3 | cerebellar granule cell differentiation (GO:0021707) | 6.52890287 |
| 4 | neuronal action potential propagation (GO:0019227) | 5.54374338 |
| 5 | response to pheromone (GO:0019236) | 5.43065705 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.16850842 |
| 7 | gamma-aminobutyric acid transport (GO:0015812) | 4.73403212 |
| 8 | myelination (GO:0042552) | 4.51518775 |
| 9 | L-amino acid import (GO:0043092) | 4.51417360 |
| 10 | ensheathment of neurons (GO:0007272) | 4.47641631 |
| 11 | axon ensheathment (GO:0008366) | 4.47641631 |
| 12 | C4-dicarboxylate transport (GO:0015740) | 4.46609866 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.28191639 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.27350802 |
| 15 | fatty acid elongation (GO:0030497) | 4.23974574 |
| 16 | cell differentiation in hindbrain (GO:0021533) | 4.18342377 |
| 17 | response to methylmercury (GO:0051597) | 4.15397001 |
| 18 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.14360551 |
| 19 | adult walking behavior (GO:0007628) | 4.09461698 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 4.04799394 |
| 21 | protein localization to synapse (GO:0035418) | 4.01604018 |
| 22 | amino acid import (GO:0043090) | 3.95829843 |
| 23 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.93564420 |
| 24 | auditory behavior (GO:0031223) | 3.89906415 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 3.87437879 |
| 26 | synaptic vesicle maturation (GO:0016188) | 3.85899649 |
| 27 | postsynaptic membrane organization (GO:0001941) | 3.82033403 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 3.76990494 |
| 29 | behavioral response to nicotine (GO:0035095) | 3.76613900 |
| 30 | negative regulation of protein localization to cell surface (GO:2000009) | 3.75539638 |
| 31 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.72405946 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 3.70875547 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.69675933 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 3.67453594 |
| 35 | transmission of nerve impulse (GO:0019226) | 3.65433681 |
| 36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.61626508 |
| 37 | negative regulation of neurotransmitter transport (GO:0051589) | 3.58681623 |
| 38 | sodium ion export (GO:0071436) | 3.52464735 |
| 39 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.50810636 |
| 40 | presynaptic membrane organization (GO:0097090) | 3.50005202 |
| 41 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.49111340 |
| 42 | activated T cell proliferation (GO:0050798) | 3.48985090 |
| 43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.45798324 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.43886198 |
| 45 | proline transport (GO:0015824) | 3.40278216 |
| 46 | cellular sodium ion homeostasis (GO:0006883) | 3.38574843 |
| 47 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.37828289 |
| 48 | neuron-neuron synaptic transmission (GO:0007270) | 3.37730184 |
| 49 | acidic amino acid transport (GO:0015800) | 3.37458201 |
| 50 | neuromuscular process controlling posture (GO:0050884) | 3.35648469 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.34968451 |
| 52 | L-glutamate transport (GO:0015813) | 3.32734802 |
| 53 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.31861919 |
| 54 | synaptic vesicle exocytosis (GO:0016079) | 3.29079805 |
| 55 | nucleobase catabolic process (GO:0046113) | 3.27628711 |
| 56 | regulation of synapse maturation (GO:0090128) | 3.26175890 |
| 57 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.24791488 |
| 58 | neurotransmitter secretion (GO:0007269) | 3.24270554 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.18637369 |
| 60 | negative regulation of inclusion body assembly (GO:0090084) | 3.17950746 |
| 61 | potassium ion import (GO:0010107) | 3.17069440 |
| 62 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.16996620 |
| 63 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.16974087 |
| 64 | dendrite morphogenesis (GO:0048813) | 3.16892858 |
| 65 | vocalization behavior (GO:0071625) | 3.14441434 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.14346098 |
| 67 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.13542810 |
| 68 | long-term memory (GO:0007616) | 3.11948905 |
| 69 | glutamate secretion (GO:0014047) | 3.11634310 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.11149304 |
| 71 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10280351 |
| 72 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.09996747 |
| 73 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.09996747 |
| 74 | exploration behavior (GO:0035640) | 3.09005722 |
| 75 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.08599780 |
| 76 | musculoskeletal movement (GO:0050881) | 3.06617666 |
| 77 | multicellular organismal movement (GO:0050879) | 3.06617666 |
| 78 | response to auditory stimulus (GO:0010996) | 3.06027077 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 2.97514451 |
| 80 | positive regulation of dendritic spine development (GO:0060999) | 2.97214129 |
| 81 | potassium ion homeostasis (GO:0055075) | 2.95627674 |
| 82 | regulation of postsynaptic membrane potential (GO:0060078) | 2.94915335 |
| 83 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.93712850 |
| 84 | regulation of neurotransmitter secretion (GO:0046928) | 2.93208682 |
| 85 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.92973815 |
| 86 | glycine transport (GO:0015816) | 2.92881875 |
| 87 | glycerophospholipid catabolic process (GO:0046475) | 2.91248391 |
| 88 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.91125753 |
| 89 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.91079625 |
| 90 | presynaptic membrane assembly (GO:0097105) | 2.90412638 |
| 91 | short-term memory (GO:0007614) | 2.87519634 |
| 92 | axonal fasciculation (GO:0007413) | 2.86901584 |
| 93 | neuronal ion channel clustering (GO:0045161) | 2.86565725 |
| 94 | membrane depolarization (GO:0051899) | 2.86300556 |
| 95 | neurotransmitter transport (GO:0006836) | 2.85259746 |
| 96 | neurofilament cytoskeleton organization (GO:0060052) | 2.84433736 |
| 97 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.84069595 |
| 98 | neuron recognition (GO:0008038) | 2.82988500 |
| 99 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.81271612 |
| 100 | regulation of synaptic vesicle transport (GO:1902803) | 2.79195831 |
| 101 | creatine metabolic process (GO:0006600) | 2.79074280 |
| 102 | detection of temperature stimulus (GO:0016048) | 2.78501819 |
| 103 | neuron remodeling (GO:0016322) | 2.76167754 |
| 104 | myelin maintenance (GO:0043217) | 2.74159909 |
| 105 | calcium ion-dependent exocytosis (GO:0017156) | 2.73602244 |
| 106 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.72260134 |
| 107 | membrane tubulation (GO:0097320) | 2.71566312 |
| 108 | dendritic spine morphogenesis (GO:0060997) | 2.71458488 |
| 109 | regulation of neurotransmitter transport (GO:0051588) | 2.71248180 |
| 110 | regulation of vesicle fusion (GO:0031338) | 2.70726777 |
| 111 | cell migration in hindbrain (GO:0021535) | 2.69234150 |
| 112 | protein localization to cilium (GO:0061512) | 2.68920563 |
| 113 | establishment of nucleus localization (GO:0040023) | 2.68646908 |
| 114 | primary amino compound metabolic process (GO:1901160) | 2.68252527 |
| 115 | serotonin metabolic process (GO:0042428) | 2.67962840 |
| 116 | sodium ion homeostasis (GO:0055078) | 2.67554491 |
| 117 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.66448700 |
| 118 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.66444342 |
| 119 | mating behavior (GO:0007617) | 2.66289411 |
| 120 | exogenous drug catabolic process (GO:0042738) | 2.65849229 |
| 121 | peripheral nervous system axon ensheathment (GO:0032292) | 2.65123735 |
| 122 | myelination in peripheral nervous system (GO:0022011) | 2.65123735 |
| 123 | synaptic transmission (GO:0007268) | 2.64450452 |
| 124 | multicellular organismal signaling (GO:0035637) | 2.63866592 |
| 125 | regulation of neurotransmitter levels (GO:0001505) | 2.63764409 |
| 126 | drug catabolic process (GO:0042737) | 2.61604595 |
| 127 | response to histamine (GO:0034776) | 2.61280322 |
| 128 | neuromuscular synaptic transmission (GO:0007274) | 2.60949312 |
| 129 | membrane hyperpolarization (GO:0060081) | 2.60392573 |
| 130 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.60297446 |
| 131 | oligodendrocyte differentiation (GO:0048709) | 2.59496035 |
| 132 | layer formation in cerebral cortex (GO:0021819) | 2.58581554 |
| 133 | neurotransmitter uptake (GO:0001504) | 2.58091608 |
| 134 | adult locomotory behavior (GO:0008344) | 2.56293724 |
| 135 | acrosome reaction (GO:0007340) | 2.53932624 |
| 136 | membrane depolarization during action potential (GO:0086010) | 2.53176026 |
| 137 | substantia nigra development (GO:0021762) | 2.52398910 |
| 138 | mechanosensory behavior (GO:0007638) | 2.50584428 |
| 139 | eye photoreceptor cell differentiation (GO:0001754) | 2.49849961 |
| 140 | photoreceptor cell differentiation (GO:0046530) | 2.49849961 |
| 141 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.48329877 |
| 142 | synapse assembly (GO:0007416) | 2.47757167 |
| 143 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.47075273 |
| 144 | long-term synaptic potentiation (GO:0060291) | 2.46244529 |
| 145 | regulation of beta-amyloid formation (GO:1902003) | 2.46206791 |
| 146 | establishment of mitochondrion localization (GO:0051654) | 2.45030656 |
| 147 | response to redox state (GO:0051775) | 2.45000917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.86454930 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86150136 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53657818 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53456467 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53340674 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38315805 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38315805 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34637055 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33008081 |
| 10 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22032223 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.19888362 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12943444 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08448938 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.06452123 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.04948708 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.03066502 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02409021 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97914428 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92995989 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92611933 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84957499 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.83524642 |
| 23 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77003543 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68999634 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.67462985 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67295820 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.67134661 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63514027 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.59184910 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57584343 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.53041642 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50975854 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50677682 |
| 34 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48358232 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43183738 |
| 36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42560656 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40474408 |
| 38 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.39755908 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39377198 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38041611 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37717367 |
| 42 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36704015 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36138939 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35447282 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33550969 |
| 46 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33490849 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30115992 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.30101102 |
| 49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27144485 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26010143 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25396379 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23439626 |
| 53 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20091835 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19361675 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19227634 |
| 56 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15497763 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14723628 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14471637 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14453957 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12899877 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11895065 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11801101 |
| 63 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09018180 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08885949 |
| 65 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08885949 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08458517 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06903642 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05654561 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05406681 |
| 70 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.03638620 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03508017 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03386183 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02808836 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02353840 |
| 75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02218225 |
| 76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01618466 |
| 77 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00645800 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00528599 |
| 79 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99933657 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99664009 |
| 81 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98635117 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98597971 |
| 83 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97101193 |
| 84 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96723332 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96608671 |
| 86 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96175212 |
| 87 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.95728162 |
| 88 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95617083 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95453575 |
| 90 | * AR_19668381_ChIP-Seq_PC3_Human | 0.94931888 |
| 91 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94783259 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94778112 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94611001 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93968627 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93627962 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93577935 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92897478 |
| 98 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92358009 |
| 99 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91150265 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90761719 |
| 101 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90479108 |
| 102 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90479108 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89917060 |
| 104 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89207525 |
| 105 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.88408835 |
| 106 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86365964 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86248780 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85689742 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85673488 |
| 110 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85439084 |
| 111 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85435762 |
| 112 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.84817332 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84704118 |
| 114 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84678258 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84568784 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84015025 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83974402 |
| 118 | TBL1_22424771_ChIP-Seq_293T_Human | 0.83781233 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.83638192 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83254277 |
| 121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82882156 |
| 122 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82879811 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82263931 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.82204883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009046_muscle_twitch | 4.57203659 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.05523782 |
| 3 | MP0000920_abnormal_myelination | 3.86656143 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.24535543 |
| 5 | MP0002272_abnormal_nervous_system | 3.24298024 |
| 6 | MP0002064_seizures | 3.10699716 |
| 7 | MP0003880_abnormal_central_pattern | 3.07814081 |
| 8 | MP0008569_lethality_at_weaning | 3.00821512 |
| 9 | MP0004270_analgesia | 2.98709922 |
| 10 | MP0002822_catalepsy | 2.80907637 |
| 11 | MP0009745_abnormal_behavioral_response | 2.79558650 |
| 12 | MP0005410_abnormal_fertilization | 2.72920699 |
| 13 | MP0004742_abnormal_vestibular_system | 2.71106007 |
| 14 | MP0003329_amyloid_beta_deposits | 2.69077242 |
| 15 | MP0003690_abnormal_glial_cell | 2.66784590 |
| 16 | MP0003787_abnormal_imprinting | 2.60673544 |
| 17 | MP0001486_abnormal_startle_reflex | 2.54321255 |
| 18 | MP0004142_abnormal_muscle_tone | 2.40201763 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.40058439 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.36280868 |
| 21 | MP0004885_abnormal_endolymph | 2.34558857 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.27126551 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.26851962 |
| 24 | MP0002063_abnormal_learning/memory/cond | 2.26435159 |
| 25 | MP0004147_increased_porphyrin_level | 2.26283614 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.24949968 |
| 27 | MP0001968_abnormal_touch/_nociception | 2.07691586 |
| 28 | MP0003632_abnormal_nervous_system | 2.04161352 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 2.02577873 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.98017274 |
| 31 | MP0000778_abnormal_nervous_system | 1.97949734 |
| 32 | MP0005365_abnormal_bile_salt | 1.92285242 |
| 33 | MP0002736_abnormal_nociception_after | 1.87091660 |
| 34 | MP0003634_abnormal_glial_cell | 1.69703530 |
| 35 | * MP0002184_abnormal_innervation | 1.68225316 |
| 36 | MP0003122_maternal_imprinting | 1.67623974 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.65391446 |
| 38 | MP0003631_nervous_system_phenotype | 1.60314446 |
| 39 | MP0001970_abnormal_pain_threshold | 1.59860127 |
| 40 | MP0000604_amyloidosis | 1.59211775 |
| 41 | * MP0000955_abnormal_spinal_cord | 1.55361441 |
| 42 | * MP0002066_abnormal_motor_capabilities/c | 1.54389346 |
| 43 | MP0004043_abnormal_pH_regulation | 1.53567029 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.53406050 |
| 45 | MP0002229_neurodegeneration | 1.53340328 |
| 46 | MP0003633_abnormal_nervous_system | 1.52911989 |
| 47 | MP0004924_abnormal_behavior | 1.52629054 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.52629054 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.51395074 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.49467374 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.48624410 |
| 52 | MP0001529_abnormal_vocalization | 1.48221207 |
| 53 | MP0005171_absent_coat_pigmentation | 1.45180996 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.44828000 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.41238278 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.40750262 |
| 57 | * MP0002882_abnormal_neuron_morphology | 1.37448727 |
| 58 | MP0001905_abnormal_dopamine_level | 1.30771901 |
| 59 | MP0001188_hyperpigmentation | 1.28757413 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.27230032 |
| 61 | MP0005083_abnormal_biliary_tract | 1.26944153 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.25541987 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.24884852 |
| 64 | MP0003123_paternal_imprinting | 1.23154758 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.21919953 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.16454628 |
| 67 | MP0005499_abnormal_olfactory_system | 1.14993043 |
| 68 | MP0005394_taste/olfaction_phenotype | 1.14993043 |
| 69 | MP0003121_genomic_imprinting | 1.14914669 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.13679815 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.12992026 |
| 72 | MP0002152_abnormal_brain_morphology | 1.07179163 |
| 73 | MP0001963_abnormal_hearing_physiology | 1.06326736 |
| 74 | MP0003136_yellow_coat_color | 1.05297977 |
| 75 | MP0002139_abnormal_hepatobiliary_system | 1.02275632 |
| 76 | MP0005535_abnormal_body_temperature | 1.01671941 |
| 77 | MP0005360_urolithiasis | 1.00225155 |
| 78 | MP0003172_abnormal_lysosome_physiology | 0.99168824 |
| 79 | MP0002102_abnormal_ear_morphology | 0.98846106 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.98121151 |
| 81 | MP0003950_abnormal_plasma_membrane | 0.97480573 |
| 82 | MP0004811_abnormal_neuron_physiology | 0.96729394 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 0.94787686 |
| 84 | MP0008872_abnormal_physiological_respon | 0.92746871 |
| 85 | MP0010329_abnormal_lipoprotein_level | 0.92233387 |
| 86 | MP0003252_abnormal_bile_duct | 0.90090580 |
| 87 | MP0001984_abnormal_olfaction | 0.89582654 |
| 88 | MP0003698_abnormal_male_reproductive | 0.89109218 |
| 89 | * MP0002752_abnormal_somatic_nervous | 0.88099183 |
| 90 | MP0003868_abnormal_feces_composition | 0.87328073 |
| 91 | MP0000462_abnormal_digestive_system | 0.86649320 |
| 92 | MP0006292_abnormal_olfactory_placode | 0.84642117 |
| 93 | MP0005448_abnormal_energy_balance | 0.82296381 |
| 94 | MP0006082_CNS_inflammation | 0.80895997 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80893825 |
| 96 | MP0001177_atelectasis | 0.77473938 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.77013344 |
| 98 | MP0008874_decreased_physiological_sensi | 0.75799345 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.75439494 |
| 100 | MP0003195_calcinosis | 0.75426660 |
| 101 | MP0002069_abnormal_eating/drinking_beha | 0.75283925 |
| 102 | MP0000569_abnormal_digit_pigmentation | 0.74875348 |
| 103 | MP0005409_darkened_coat_color | 0.74828716 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.74154968 |
| 105 | MP0000631_abnormal_neuroendocrine_gland | 0.72823278 |
| 106 | MP0002090_abnormal_vision | 0.72554534 |
| 107 | MP0004134_abnormal_chest_morphology | 0.71445723 |
| 108 | MP0000579_abnormal_nail_morphology | 0.71265582 |
| 109 | MP0000566_synostosis | 0.68780260 |
| 110 | MP0003938_abnormal_ear_development | 0.67590927 |
| 111 | MP0001664_abnormal_digestion | 0.67301553 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.66343800 |
| 113 | MP0000747_muscle_weakness | 0.66341302 |
| 114 | MP0005646_abnormal_pituitary_gland | 0.65544847 |
| 115 | MP0005253_abnormal_eye_physiology | 0.65262927 |
| 116 | MP0008789_abnormal_olfactory_epithelium | 0.64691298 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.63387318 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.62822982 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62617891 |
| 120 | MP0003283_abnormal_digestive_organ | 0.61866963 |
| 121 | MP0001851_eye_inflammation | 0.61195758 |
| 122 | * MP0004145_abnormal_muscle_electrophysio | 0.59662944 |
| 123 | MP0003879_abnormal_hair_cell | 0.59601890 |
| 124 | MP0005195_abnormal_posterior_eye | 0.58441134 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.58424590 |
| 126 | MP0000467_abnormal_esophagus_morphology | 0.57281169 |
| 127 | MP0000026_abnormal_inner_ear | 0.55688608 |
| 128 | MP0005332_abnormal_amino_acid | 0.54065851 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.53720047 |
| 130 | MP0010769_abnormal_survival | 0.52857633 |
| 131 | MP0002118_abnormal_lipid_homeostasis | 0.52407624 |
| 132 | MP0002161_abnormal_fertility/fecundity | 0.51293136 |
| 133 | MP0009840_abnormal_foam_cell | 0.50420614 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.49953143 |
| 135 | MP0010770_preweaning_lethality | 0.49881415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Action tremor (HP:0002345) | 6.27092694 |
| 2 | Scanning speech (HP:0002168) | 5.24722039 |
| 3 | Intention tremor (HP:0002080) | 5.22079360 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 5.19187971 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.97286269 |
| 6 | Gaze-evoked nystagmus (HP:0000640) | 4.85539262 |
| 7 | Focal motor seizures (HP:0011153) | 4.72578448 |
| 8 | Myokymia (HP:0002411) | 4.59763072 |
| 9 | Dysmetria (HP:0001310) | 4.59009836 |
| 10 | Abnormality of the corticospinal tract (HP:0002492) | 4.58488908 |
| 11 | Limb dystonia (HP:0002451) | 4.28935106 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.20445394 |
| 13 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.20445394 |
| 14 | Dysdiadochokinesis (HP:0002075) | 4.11573485 |
| 15 | Focal seizures (HP:0007359) | 3.80099394 |
| 16 | Atonic seizures (HP:0010819) | 3.79790501 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.72038244 |
| 18 | Visual hallucinations (HP:0002367) | 3.69102558 |
| 19 | Cerebral inclusion bodies (HP:0100314) | 3.56403020 |
| 20 | Spastic gait (HP:0002064) | 3.54611915 |
| 21 | Broad-based gait (HP:0002136) | 3.46005514 |
| 22 | Peripheral hypomyelination (HP:0007182) | 3.27435090 |
| 23 | Abnormality of saccadic eye movements (HP:0000570) | 3.11255951 |
| 24 | Hemiparesis (HP:0001269) | 3.05383118 |
| 25 | Diplopia (HP:0000651) | 3.03907258 |
| 26 | Abnormality of binocular vision (HP:0011514) | 3.03907258 |
| 27 | Dysmetric saccades (HP:0000641) | 3.01694160 |
| 28 | Hemiplegia (HP:0002301) | 3.01365485 |
| 29 | Spastic tetraparesis (HP:0001285) | 2.98567454 |
| 30 | Postural tremor (HP:0002174) | 2.98386795 |
| 31 | Impaired smooth pursuit (HP:0007772) | 2.97133920 |
| 32 | Epileptic encephalopathy (HP:0200134) | 2.95813356 |
| 33 | Sensory axonal neuropathy (HP:0003390) | 2.95256787 |
| 34 | Truncal ataxia (HP:0002078) | 2.92485409 |
| 35 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.87774375 |
| 36 | Polyphagia (HP:0002591) | 2.84951860 |
| 37 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.82535952 |
| 38 | Gait imbalance (HP:0002141) | 2.82342852 |
| 39 | Tetraplegia (HP:0002445) | 2.80582038 |
| 40 | Cerebral hypomyelination (HP:0006808) | 2.77338986 |
| 41 | Ankle clonus (HP:0011448) | 2.72614581 |
| 42 | Onion bulb formation (HP:0003383) | 2.63764987 |
| 43 | Split foot (HP:0001839) | 2.60959348 |
| 44 | Febrile seizures (HP:0002373) | 2.54161230 |
| 45 | Genetic anticipation (HP:0003743) | 2.51256441 |
| 46 | Neuronal loss in central nervous system (HP:0002529) | 2.51120810 |
| 47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.47951941 |
| 48 | Drooling (HP:0002307) | 2.47768512 |
| 49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.47061634 |
| 50 | Absence seizures (HP:0002121) | 2.46965343 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.44672838 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.43020940 |
| 53 | Torticollis (HP:0000473) | 2.42401006 |
| 54 | Pheochromocytoma (HP:0002666) | 2.39611475 |
| 55 | Status epilepticus (HP:0002133) | 2.39005002 |
| 56 | Dialeptic seizures (HP:0011146) | 2.37716932 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.36835902 |
| 58 | Oligodactyly (hands) (HP:0001180) | 2.33835848 |
| 59 | Alacrima (HP:0000522) | 2.32629616 |
| 60 | Gait ataxia (HP:0002066) | 2.31306990 |
| 61 | Excessive salivation (HP:0003781) | 2.30935975 |
| 62 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.29929126 |
| 63 | Confusion (HP:0001289) | 2.26297150 |
| 64 | Abnormal ciliary motility (HP:0012262) | 2.25393011 |
| 65 | Limb ataxia (HP:0002070) | 2.24844890 |
| 66 | Clonus (HP:0002169) | 2.24608729 |
| 67 | Congenital primary aphakia (HP:0007707) | 2.23063735 |
| 68 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.22298202 |
| 69 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.22298202 |
| 70 | Postural instability (HP:0002172) | 2.19984805 |
| 71 | Focal dystonia (HP:0004373) | 2.19962166 |
| 72 | Absent/shortened dynein arms (HP:0200106) | 2.19439102 |
| 73 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19439102 |
| 74 | Poor eye contact (HP:0000817) | 2.16989532 |
| 75 | EEG with generalized epileptiform discharges (HP:0011198) | 2.16936341 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.16884733 |
| 77 | Termporal pattern (HP:0011008) | 2.16476725 |
| 78 | Insidious onset (HP:0003587) | 2.16476725 |
| 79 | Amyotrophic lateral sclerosis (HP:0007354) | 2.15323411 |
| 80 | Generalized tonic-clonic seizures (HP:0002069) | 2.14871602 |
| 81 | Anxiety (HP:0000739) | 2.13633454 |
| 82 | Abnormal auditory evoked potentials (HP:0006958) | 2.13493484 |
| 83 | Ventricular fibrillation (HP:0001663) | 2.11968335 |
| 84 | Neuroendocrine neoplasm (HP:0100634) | 2.10152404 |
| 85 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09837002 |
| 86 | Mutism (HP:0002300) | 2.09294892 |
| 87 | Cerebral hemorrhage (HP:0001342) | 2.08899168 |
| 88 | Papilledema (HP:0001085) | 2.08609843 |
| 89 | Abnormal eating behavior (HP:0100738) | 2.07741870 |
| 90 | Hyperventilation (HP:0002883) | 2.07680217 |
| 91 | Sleep apnea (HP:0010535) | 2.06469305 |
| 92 | Anteriorly placed anus (HP:0001545) | 2.04623429 |
| 93 | Spastic tetraplegia (HP:0002510) | 2.03908874 |
| 94 | Slow saccadic eye movements (HP:0000514) | 2.03294674 |
| 95 | Type II lissencephaly (HP:0007260) | 2.03086374 |
| 96 | Clumsiness (HP:0002312) | 2.02829991 |
| 97 | CNS hypomyelination (HP:0003429) | 2.01539917 |
| 98 | Depression (HP:0000716) | 2.01412254 |
| 99 | Slow progression (HP:0003677) | 2.00981818 |
| 100 | Retinal dysplasia (HP:0007973) | 2.00536182 |
| 101 | Generalized myoclonic seizures (HP:0002123) | 2.00095757 |
| 102 | Impaired social interactions (HP:0000735) | 1.98904830 |
| 103 | Abnormal social behavior (HP:0012433) | 1.98904830 |
| 104 | Specific learning disability (HP:0001328) | 1.98781868 |
| 105 | Psychosis (HP:0000709) | 1.97326480 |
| 106 | Chronic hepatic failure (HP:0100626) | 1.96285427 |
| 107 | Premature skin wrinkling (HP:0100678) | 1.95376489 |
| 108 | Genital tract atresia (HP:0001827) | 1.95033895 |
| 109 | Megalencephaly (HP:0001355) | 1.94959469 |
| 110 | Vaginal atresia (HP:0000148) | 1.94923301 |
| 111 | Potter facies (HP:0002009) | 1.89947314 |
| 112 | Facial shape deformation (HP:0011334) | 1.89947314 |
| 113 | Choreoathetosis (HP:0001266) | 1.89728672 |
| 114 | Urinary urgency (HP:0000012) | 1.89486586 |
| 115 | Lower limb muscle weakness (HP:0007340) | 1.89228601 |
| 116 | Horizontal nystagmus (HP:0000666) | 1.88398425 |
| 117 | Glycosuria (HP:0003076) | 1.88383576 |
| 118 | Abnormality of urine glucose concentration (HP:0011016) | 1.88383576 |
| 119 | Amblyopia (HP:0000646) | 1.86411063 |
| 120 | Agitation (HP:0000713) | 1.85798731 |
| 121 | Syncope (HP:0001279) | 1.84900808 |
| 122 | Decreased lacrimation (HP:0000633) | 1.84443716 |
| 123 | Prolonged QT interval (HP:0001657) | 1.83637115 |
| 124 | Abnormality of the lower motor neuron (HP:0002366) | 1.83224526 |
| 125 | Dysarthria (HP:0001260) | 1.82985385 |
| 126 | Inability to walk (HP:0002540) | 1.82748480 |
| 127 | Hepatoblastoma (HP:0002884) | 1.82318801 |
| 128 | Decreased circulating renin level (HP:0003351) | 1.81816142 |
| 129 | Blue irides (HP:0000635) | 1.81692899 |
| 130 | Absent speech (HP:0001344) | 1.79992415 |
| 131 | Choroideremia (HP:0001139) | 1.79147794 |
| 132 | Increased circulating renin level (HP:0000848) | 1.79038634 |
| 133 | Metabolic alkalosis (HP:0200114) | 1.77808095 |
| 134 | Hypobetalipoproteinemia (HP:0003563) | 1.77541681 |
| 135 | Craniofacial dystonia (HP:0012179) | 1.77357748 |
| 136 | Spastic paraplegia (HP:0001258) | 1.77081837 |
| 137 | Abnormality of midbrain morphology (HP:0002418) | 1.76949406 |
| 138 | Molar tooth sign on MRI (HP:0002419) | 1.76949406 |
| 139 | Synostosis involving the elbow (HP:0003938) | 1.76869776 |
| 140 | Humeroradial synostosis (HP:0003041) | 1.76869776 |
| 141 | Nephronophthisis (HP:0000090) | 1.76869169 |
| 142 | True hermaphroditism (HP:0010459) | 1.76003186 |
| 143 | Hyperglycinuria (HP:0003108) | 1.76002311 |
| 144 | Cerebellar atrophy (HP:0001272) | 1.75789425 |
| 145 | Poor speech (HP:0002465) | 1.75486317 |
| 146 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.73249858 |
| 147 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.73221989 |
| 148 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72665196 |
| 149 | Hydroxyprolinuria (HP:0003080) | 1.72110749 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 1.72110749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.00357251 |
| 2 | OXSR1 | 3.46881698 |
| 3 | TYRO3 | 2.95625976 |
| 4 | EPHB1 | 2.91810982 |
| 5 | CDK19 | 2.83385809 |
| 6 | WNK1 | 2.79574586 |
| 7 | PRPF4B | 2.52987935 |
| 8 | CAMKK2 | 2.50695110 |
| 9 | PKN1 | 2.16114292 |
| 10 | ICK | 2.01913458 |
| 11 | PNCK | 1.94295018 |
| 12 | TNIK | 1.90099246 |
| 13 | BCR | 1.83974313 |
| 14 | MAPKAPK5 | 1.81693575 |
| 15 | NEK6 | 1.80715596 |
| 16 | CASK | 1.80109880 |
| 17 | NTRK2 | 1.68232771 |
| 18 | PAK6 | 1.67145724 |
| 19 | FGFR2 | 1.63521293 |
| 20 | FRK | 1.63096014 |
| 21 | UHMK1 | 1.60872075 |
| 22 | FES | 1.60378268 |
| 23 | NTRK3 | 1.60061746 |
| 24 | MARK1 | 1.56911149 |
| 25 | SGK223 | 1.46748942 |
| 26 | SGK494 | 1.46748942 |
| 27 | NTRK1 | 1.42676320 |
| 28 | WNK4 | 1.41521913 |
| 29 | SIK2 | 1.39479135 |
| 30 | DYRK2 | 1.38247956 |
| 31 | MAP3K4 | 1.36307204 |
| 32 | SGK2 | 1.35713573 |
| 33 | ROCK2 | 1.35428034 |
| 34 | MINK1 | 1.33691060 |
| 35 | CAMKK1 | 1.32922638 |
| 36 | CAMK2B | 1.31549649 |
| 37 | MAP3K9 | 1.25768273 |
| 38 | CAMK2G | 1.25671202 |
| 39 | LIMK1 | 1.25506397 |
| 40 | RIPK1 | 1.21792447 |
| 41 | IRAK2 | 1.20397665 |
| 42 | ACVR1B | 1.19187280 |
| 43 | DAPK2 | 1.18853655 |
| 44 | CAMK1G | 1.15374905 |
| 45 | TESK2 | 1.12360356 |
| 46 | CAMK2D | 1.10907564 |
| 47 | ADRBK2 | 1.04709584 |
| 48 | WNK3 | 1.04694902 |
| 49 | CDK5 | 1.02949373 |
| 50 | PDPK1 | 1.01962855 |
| 51 | MAP2K7 | 0.97935594 |
| 52 | DYRK1B | 0.97922291 |
| 53 | MAP2K4 | 0.94681616 |
| 54 | MAPK13 | 0.94559946 |
| 55 | PDK1 | 0.94342843 |
| 56 | CDK15 | 0.92732890 |
| 57 | PRKCH | 0.92339152 |
| 58 | CDK18 | 0.90623715 |
| 59 | CAMK2A | 0.89502095 |
| 60 | PRKCG | 0.88057078 |
| 61 | CSNK1G2 | 0.87990640 |
| 62 | CSNK1G3 | 0.87042020 |
| 63 | CSNK1A1L | 0.86273438 |
| 64 | BMPR1B | 0.86168681 |
| 65 | CDK14 | 0.85108202 |
| 66 | PDK2 | 0.83382529 |
| 67 | EPHA4 | 0.83140780 |
| 68 | PRKCZ | 0.82895612 |
| 69 | PLK2 | 0.82673813 |
| 70 | CDK11A | 0.81934286 |
| 71 | MARK2 | 0.77795911 |
| 72 | PBK | 0.77659706 |
| 73 | PINK1 | 0.76103317 |
| 74 | STK38 | 0.75252559 |
| 75 | PIK3CA | 0.73458199 |
| 76 | TAOK3 | 0.73040011 |
| 77 | STK11 | 0.72026640 |
| 78 | PHKG1 | 0.70525920 |
| 79 | PHKG2 | 0.70525920 |
| 80 | MAP3K13 | 0.69023775 |
| 81 | PRKCQ | 0.68465370 |
| 82 | RIPK4 | 0.67914369 |
| 83 | PTK2 | 0.66981936 |
| 84 | PRKG1 | 0.66003796 |
| 85 | CAMK1 | 0.65674412 |
| 86 | * FYN | 0.63819898 |
| 87 | MET | 0.63715037 |
| 88 | SGK3 | 0.63408579 |
| 89 | GRK1 | 0.58328337 |
| 90 | KSR2 | 0.57395701 |
| 91 | EPHA3 | 0.56727504 |
| 92 | CSNK1G1 | 0.56205488 |
| 93 | RET | 0.53858597 |
| 94 | GRK5 | 0.52604311 |
| 95 | PRKCA | 0.52565468 |
| 96 | PDK3 | 0.51310963 |
| 97 | PDK4 | 0.51310963 |
| 98 | INSRR | 0.51166453 |
| 99 | CSK | 0.50550779 |
| 100 | PTK6 | 0.50017659 |
| 101 | ITK | 0.49924238 |
| 102 | FGR | 0.48840501 |
| 103 | PDGFRB | 0.48831152 |
| 104 | MAP4K2 | 0.48580531 |
| 105 | PRKD3 | 0.48526389 |
| 106 | KSR1 | 0.48225841 |
| 107 | DAPK1 | 0.47613736 |
| 108 | PRKACG | 0.46010953 |
| 109 | ERBB2 | 0.45451314 |
| 110 | INSR | 0.44527371 |
| 111 | PAK3 | 0.44105842 |
| 112 | MAPK15 | 0.43756879 |
| 113 | DYRK1A | 0.43712145 |
| 114 | PRKACB | 0.43704879 |
| 115 | CAMK4 | 0.43636893 |
| 116 | PRKD1 | 0.42587563 |
| 117 | TAOK1 | 0.40324427 |
| 118 | RPS6KA3 | 0.40311305 |
| 119 | SGK1 | 0.40235651 |
| 120 | CSNK1A1 | 0.40232019 |
| 121 | * SRC | 0.39659841 |
| 122 | ARAF | 0.39452038 |
| 123 | PRKAA1 | 0.39440633 |
| 124 | PRKCE | 0.39366275 |
| 125 | PRKACA | 0.39245630 |
| 126 | CSNK1E | 0.36677169 |
| 127 | PRKCB | 0.33381716 |
| 128 | BMPR2 | 0.30487735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.35167585 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.78531944 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.51640233 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.45316036 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34096973 |
| 6 | Long-term depression_Homo sapiens_hsa04730 | 2.28112939 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27522485 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.15660859 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02113120 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.00783650 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.95377567 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.90657465 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.89693267 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85074659 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.84161730 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.83951199 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.79534999 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71120502 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.69450340 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69404887 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65904152 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.63545318 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.63409567 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.44540316 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.44435434 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43820655 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.38148612 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35686186 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33213569 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30524757 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29799297 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27363582 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.26077986 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25914020 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23145598 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19631405 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18125213 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16423961 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.15933056 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.15029709 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14805221 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13272083 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11426596 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11419425 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.07244139 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03911508 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02124532 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99108246 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98822937 |
| 50 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97880124 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96161125 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95848525 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 0.95742267 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95125084 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94956289 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94196180 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93820704 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.92330393 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91283550 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90468204 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88710947 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87917212 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.86807415 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86076378 |
| 65 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83878668 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83453168 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82404385 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81378284 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80935557 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80533824 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.80239712 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79919588 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78393555 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77932569 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.77736898 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77213631 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.76864688 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76479927 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76339772 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75506180 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75416311 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75376754 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71676969 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71590973 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69377341 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69045665 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68445000 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.68321018 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67739537 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66419573 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66272153 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64570815 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64027739 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63246117 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62520673 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62371824 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61639791 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61615500 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58688709 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55997048 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55618720 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53675185 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53060013 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.52364701 |
| 105 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51224022 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49783343 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47706862 |
| 108 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47495058 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47110045 |
| 110 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46976250 |
| 111 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46957363 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45343197 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.45091920 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.44825283 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44458208 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44426591 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43616654 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43027369 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41789770 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.41318093 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39719053 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37577270 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37446198 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.37041168 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36885276 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35774668 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.35116548 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34715175 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34322605 |

